{"id":"tp-32983","type":"article-newspaper","title":"Moderna Shares Rise 4.5% Ahead of Melanoma Trial Results","author":"Enna Lee","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/investing/32983","datePublished":"2026-10-16T03:16:44.000Z","dateModified":"2026-10-16T03:16:44.000Z","language":"en","abstract":"The Phase 3 INTerpath-001 findings are scheduled for presentation Oct. 24 in Madrid. The companies disclosed no numerical efficacy results in August.","section":"Investing","references":[{"title":"previous session","url":"https://www.tokenpost.com/news/investing/29269"}]}